Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Clinical Immunology and Immunopathology
|
February 1, 1997
Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice
A Katsume, T Miyai, H Suzuki, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
May 18, 2001
NHE and ICAM-1 expression in hypoxic/reoxygenated coronary microvascular endothelial cells
R Hattori, H Otani, Y Moriguchi, et al.
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1993
Bone metastasis as a prognostic factor in breast cancer patients with liver metastasis given OK-432-combined adoptive immunotherapy via the hepatic artery
N Kan, S Yamasaki, H Kodama, et al.
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1993
Sequential immunotherapy using interleukin-1 followed by interleukin-2 of ascitic MOPC104E-bearing mice
T Harada, N Kan, T Okino, et al.
Journal of Surgical Oncology
|
June 1, 1996
A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor system
Y Moriguchi, N Kan, T Okino, et al.
Surgery Today
|
January 1, 1994
The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine model
T Harada, N Kan, T Okino, et al.
Surgery Today
|
April 22, 1999
Reduction of tumorigenicity by an interferon-gamma-gene-transduced tumor on another syngeneic tumor in a murine model
Y Ichinose, T Okino, S Yamasaki, et al.
Genes, Brain, and Behavior
|
September 13, 2008
Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease
R Hashimoto, Y Hirata, T Asada, et al.
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1993
The induction of murine tumor infiltrating lymphocytes (TIL) by interleukin-2 or T cell growth factor
N Kan, K Mise, M Nakanishi, et al.
Breast Cancer Research and Treatment
|
January 1, 1993
Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy
S Yamasaki, N Kan, T Harada, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Clinical Immunology and Immunopathology
|
February 1, 1997
Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice
A Katsume, T Miyai, H Suzuki, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
May 18, 2001
NHE and ICAM-1 expression in hypoxic/reoxygenated coronary microvascular endothelial cells
R Hattori, H Otani, Y Moriguchi, et al.
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1993
Bone metastasis as a prognostic factor in breast cancer patients with liver metastasis given OK-432-combined adoptive immunotherapy via the hepatic artery
N Kan, S Yamasaki, H Kodama, et al.
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1993
Sequential immunotherapy using interleukin-1 followed by interleukin-2 of ascitic MOPC104E-bearing mice
T Harada, N Kan, T Okino, et al.
Journal of Surgical Oncology
|
June 1, 1996
A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor system
Y Moriguchi, N Kan, T Okino, et al.
Surgery Today
|
January 1, 1994
The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine model
T Harada, N Kan, T Okino, et al.
Surgery Today
|
April 22, 1999
Reduction of tumorigenicity by an interferon-gamma-gene-transduced tumor on another syngeneic tumor in a murine model
Y Ichinose, T Okino, S Yamasaki, et al.
Genes, Brain, and Behavior
|
September 13, 2008
Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease
R Hashimoto, Y Hirata, T Asada, et al.
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1993
The induction of murine tumor infiltrating lymphocytes (TIL) by interleukin-2 or T cell growth factor
N Kan, K Mise, M Nakanishi, et al.
Breast Cancer Research and Treatment
|
January 1, 1993
Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy
S Yamasaki, N Kan, T Harada, et al.
Page
of 5